Michael Tam

Dr Michael Tam is a clinical academic Specialist General Practitioner, combining the provision of family medicine, research, health services development, and governance. Michael’s clinical interest is in the whole-person primary care of people living with mental illness. He is actively involved in mental health policy, strategy, and governance, with local, state, and national bodies. Michael’s research is in integrated care and preventive care in general practice. He has expertise in both qualitative and quantitative research methods.

Most commented posts

  1. Incidence and progression of thyroid dysfunction in elderly — 2 comments
  2. Glucosamine and/or chondroitin for osteoarthritis — 2 comments
  3. N95 respirators vs surgical masks to prevent transmission of respiratory tract infections to staff in primary care — 1 comments
  4. Zinc for the common cold — 1 comments
  5. Daily aspirin on long-term risk of death due to cancer — 1 comments

Author's posts

Jan 21 2011

Chronic kidney disease and risk of cardiovascular disease

Di Angelantonio E, et al. CKD and risk of major CVD and no-vascular mortality: prospective population based cohort study. BMJ. 2010;341:c4986
Even the earliest stages of CKD seem to be independently associated with an increased risk of subsequent CHD.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=262

Jan 19 2011

Reboxetine for acute treatment of major depression

Eyding D, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and SSRI. BMJ 2010;341:c4737
Reboxetine is no more effective than placebo for major depressive disorder.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=250

Jan 14 2011

Placebos for irritable bowel syndrome

Kaptchuk TJ, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010; 5(12): e15591
The positive results widely reported for placebo pills in consenting patients with irritable bowel syndrome are likely invalid due to serious methodological limitations in the study.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=749

Jan 12 2011

Severe hypoglycemia and risk of vascular events and death

Zoungas S, et al. Severe hypoglycemia and risk of vascular events and death. N Engl J Med 2010;363:1410-8
Severe hypoglycaemia is strongly associated with increased risk of vascular events and death (~ 350% ↑ risk).

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=206

Jan 05 2011

Subclinical hypothyroidism and coronary heart disease

Rondondi N, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374.
Subclinical hypothyroidism (elevated TSH with normal thyroxine levels) is associated with increased risk of coronary heart disease (CHD) events and mortality.

Permanent link to this article: https://evidencebasedmedicine.com.au/?p=162

Load more